Fouqueray, P., Pirags, V., Inzucchi, S. E., Bailey, C. J., Schernthaner, G., Diamant, M., & Lebovitz, H. E. (2013). The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy. American Diabetes Association.
Stile di citazione ChicagoFouqueray, Pascale, Valdis Pirags, Silvio E. Inzucchi, Clifford J. Bailey, Guntram Schernthaner, Michaela Diamant, e Harold E. Lebovitz. The Efficacy and Safety of Imeglimin As Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy. American Diabetes Association, 2013.
Citazione MLAFouqueray, Pascale, et al. The Efficacy and Safety of Imeglimin As Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy. American Diabetes Association, 2013.